After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Zymeworks BC Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Zymeworks BC Inc is $767.41M. A total of 0.57 million shares were traded on the day, compared to an average of 617.76K shares.
In the most recent transaction, EcoR1 Capital, LLC bought 196,438 shares of ZYME for 11.17 per share on Apr 04 ’25. After the transaction, the Director now owns 17,699,774 company shares. In a previous transaction on Apr 03 ’25, EcoR1 Capital, LLC bought 120,770 shares at 11.84 per share. ZYME shares that Director owns now total 17,503,336.
Among the insiders who bought shares, EcoR1 Capital, LLC acquired of 74,360 shares on Apr 02 ’25 at a per-share price of $11.85. This resulted in the Director holding 17,382,566 shares of ZYME after the transaction. In another insider transaction, EcoR1 Capital, LLC bought 48,658 shares at $11.60 per share on Apr 01 ’25. Company shares held by the Director now total 17,308,206.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ZYME has a high of $17.70 and a low of $7.97.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ZYME’s latest balance sheet shows that the firm has $252.61M in Cash & Short Term Investments as of fiscal 2021. There were $32.33M in debt and $71.85M in liabilities at the time. Its Book Value Per Share was $4.87, while its Total Shareholder’s Equity was $249.09M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZYME is Buy with a score of 4.60.
